Cargando…
Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas
BACKGROUND: uPA, its receptor uPAR, and inhibitors PAI‐1 and PAI‐2 play key roles in membrane remodeling/invasion and in predicting response to chemotherapy. We identified novel relationships of these biomarkers with ER/PR that indicate clinical utility for assessing breast carcinoma outcomes. METHO...
Autores principales: | Sereff, Seth B., Daniels, Michael W., Wittliff, James L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868412/ https://www.ncbi.nlm.nih.gov/pubmed/31359505 http://dx.doi.org/10.1002/jcla.22982 |
Ejemplares similares
-
Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022) -
Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas
por: Ulisse, Salvatore, et al.
Publicado: (2010) -
Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods.
por: Bouchet, C., et al.
Publicado: (1998) -
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998) -
Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
por: Cantero, D., et al.
Publicado: (1997)